GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 198 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $861,000 | +113.1% | 12,644 | 0.0% | 0.01% | +100.0% |
| Q2 2022 | $404,000 | -7.8% | 12,644 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $438,000 | +18.4% | 12,644 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $370,000 | +14.9% | 12,644 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $322,000 | -27.3% | 12,644 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $443,000 | -14.0% | 12,644 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $515,000 | -6.0% | 12,644 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $548,000 | -21.4% | 12,644 | 0.0% | 0.00% | -40.0% |
| Q3 2020 | $697,000 | -56.3% | 12,644 | -50.0% | 0.01% | -28.6% |
| Q2 2020 | $1,596,000 | – | 25,288 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 383,702 | $14,581,000 | 7.71% |
| Perceptive Advisors | 5,148,910 | $195,658,000 | 5.23% |
| Grace Capital | 312,514 | $11,876,000 | 4.65% |
| NEXTHERA CAPITAL LP | 549,231 | $20,871,000 | 4.00% |
| Asymmetry Capital Management, L.P. | 103,449 | $3,931,000 | 3.63% |
| Camber Capital Management LP | 2,075,000 | $78,850,000 | 3.37% |
| Casdin Capital, LLC | 440,000 | $16,720,000 | 2.03% |
| EMORY UNIVERSITY | 53,951 | $2,050,000 | 1.34% |
| ArchPoint Investors | 129,435 | $4,919,000 | 1.34% |
| Ghost Tree Capital, LLC | 150,000 | $5,700,000 | 1.21% |